Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin (2016 - 2025)

OptimizeRx's EBT Margin history spans 16 years, with the latest figure at 4.03% for Q3 2025.

  • For Q3 2025, EBT Margin rose 5068.0% year-over-year to 4.03%; the TTM value through Sep 2025 reached 1.54%, up 3934.0%, while the annual FY2024 figure was 21.04%, 1414.0% up from the prior year.
  • EBT Margin for Q3 2025 was 4.03% at OptimizeRx, down from 5.87% in the prior quarter.
  • Across five years, EBT Margin topped out at 6.83% in Q4 2024 and bottomed at 49.2% in Q1 2023.
  • The 5-year median for EBT Margin is 17.54% (2023), against an average of 16.99%.
  • The largest annual shift saw EBT Margin plummeted -3972bps in 2023 before it surged 5068bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 3.07% in 2021, then crashed by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then skyrocketed by 117bps to 6.83% in 2024, then crashed by -41bps to 4.03% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's EBT Margin are 4.03% (Q3 2025), 5.87% (Q2 2025), and 14.98% (Q1 2025).